Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy
Overview of attention for article published in Haemophilia, May 2013
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (77th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Readers on
- mendeley
- 67 Mendeley